Isolation of seven distinct carbapenemase-producing Gram-negative organisms from a single patient

J Antimicrob Chemother. 2017 Jan;72(1):317-319. doi: 10.1093/jac/dkw378. Epub 2016 Sep 12.

Authors

Julie Creighton¹, Helen Heffernan², Julia Howard³

Affiliations

¹ Canterbury Health Laboratories, Christchurch, New Zealand julie.creighton@cdhb.health.nz.
² Antibiotic Reference Laboratory, Institute for Environmental Science and Research (ESR), Wellington, New Zealand.
³ Canterbury Health Laboratories, Christchurch, New Zealand.

PMID: 27621176
DOI: 10.1093/jac/dkw378

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acinetobacter Infections / drug therapy
Acinetobacter Infections / microbiology
Acinetobacter baumannii / drug effects*
Acinetobacter baumannii / isolation & purification
Bacterial Proteins / biosynthesis*
Bacterial Proteins / metabolism
Drug Resistance, Bacterial
Humans
Klebsiella Infections / drug therapy
Klebsiella Infections / microbiology
Klebsiella pneumoniae / drug effects*
Klebsiella pneumoniae / isolation & purification
Microbial Sensitivity Tests
New Zealand
Proteus Infections / drug therapy
Proteus Infections / microbiology
Proteus mirabilis / drug effects*
Proteus mirabilis / isolation & purification
Providencia / drug effects*
Providencia / isolation & purification
Pseudomonas Infections / drug therapy
Pseudomonas Infections / microbiology
Pseudomonas aeruginosa / drug effects*
Pseudomonas aeruginosa / isolation & purification
beta-Lactamases / biosynthesis*
beta-Lactamases / metabolism*

Substances

Bacterial Proteins
beta-lactamase KPC-2
beta-Lactamases
beta-lactamase NDM-1
carbapenemase
oxacillinase